The pharmaceutical industry is experiencing a shift from blockbusters to biological drugs for more personalized treatments. This trend results in a need for pharmaceutical companies to manufacture smaller batches and handle multiple products in different packaging presentations on the same filling line, driving the adoption of Ready-To-Use (RTU) primary packaging formats. Although the technology of combi-lines and RTU is well established in the market, there are still only few options for primary packaging available.
To ensure manufacturing readiness, a key aspect pharma companies have to take into account when selecting the technology is the possibility of multiple sourcing along their supply chain. Flexibility, quality and low Total Cost of Ownership (TCO) are key parameters when selecting packaging partners for fill & finish operations.
This webinar demonstrates how the partnership between Stevanato Group and SGD Pharma on RTU molded glass vials supports companies needing to switch manufacturing process from bulk to EZ-fill®.
Content of the Webinar:
· Pharmaceutical megatrends
· Ready-to-Use for aseptic manufacturing
· SG EZ-fill® pre-sterilized platform
· Sterinity ®: Molded glass Ready-To-Use platform
· Case study: TERIAK, presented by Noureddine Ghariani, the head of Biologic Project and Site Manager of ELFEJJA Teriak.
· Conclusion
Key Learning Objectives
- Understand how SG EZ-Fill pre-sterilized platform can help your pharma company gain in flexibility
- Learn more about a real case study on multi-sourcing approach
- Get insights from leading market players about the aseptic manufacturing using Ready To Fill containers
- Get to know Sterinity: benefits of pre-sterilized molded glass
